Related content

Adjuvant Therapy for Stage II Colon Cancer: Prognostic and Predictive Markers

By Vicuna Brian   Benson Al B.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 9, 2007-10 ,pp. : 927-936

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer

By Kumar Aalok   Kennecke Hagen F.   Renouf Daniel J.   Lim Howard J.   Gill Sharlene   Woods Ryan   Speers Caroline   Cheung Winson Y.  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 527-534

Blackwell Publishing

Access to resources Recommend Favorite

Prognostic Significance of Thrombocytosis in Node-negative Colon Cancer

By Kandemir EG   Mayadagli A   Karagoz B   Bilgi O   Turken O   Yaylaci M  

The Journal of International Medical Research, Vol. 33, Iss. 2, 2005-03 ,pp. : 228-235

Field House Publishing

Access to resources Recommend Favorite

VEGF and Colon Cancer Growth Beyond Angiogenesis: Does VEGF Directly Mediate Colon Cancer Growth Via a Non-angiogenic Mechanism?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1041-1044

Bentham Science Publishers

Access to resources Recommend Favorite

Fragmentation in specialist care and stage III colon cancer

By Hussain Tanvir   Chang Hsien-Yen   Veenstra Christine M.   Pollack Craig Evan  

Cancer, Vol. 121, Iss. 18, 2015-09 ,pp. : 3316-3324

Blackwell Publishing

Access to resources Recommend Favorite